AR012125A1 - UNA SAL DE UN COMPUESTO DERIVADO DEL ÁCIDO NAFTIRIDINA CARBOXíLICO , SU USO PARA LA FABRICACIoN DE UN MEDICAMENTO , PROCEDIMIENTO PARA PREPARARLA Y UNA COMPOSICIoN FARMACÉUTICA QUE LO COMPRENDE - Google Patents

UNA SAL DE UN COMPUESTO DERIVADO DEL ÁCIDO NAFTIRIDINA CARBOXíLICO , SU USO PARA LA FABRICACIoN DE UN MEDICAMENTO , PROCEDIMIENTO PARA PREPARARLA Y UNA COMPOSICIoN FARMACÉUTICA QUE LO COMPRENDE

Info

Publication number
AR012125A1
AR012125A1 ARP980101268A ARP980101268A AR012125A1 AR 012125 A1 AR012125 A1 AR 012125A1 AR P980101268 A ARP980101268 A AR P980101268A AR P980101268 A ARP980101268 A AR P980101268A AR 012125 A1 AR012125 A1 AR 012125A1
Authority
AR
Argentina
Prior art keywords
naftiridine
carboxyllic
prepare
salt
procedure
Prior art date
Application number
ARP980101268A
Other languages
English (en)
Spanish (es)
Inventor
Ryoo Choi Jong
Hyun Nam Do
Ri Kim Ae
Hwa Lee Jin
Hee Lee Tae
Choi Hoon
Sook Park Ki
Hyok Chang Jay
Original Assignee
Lg Life Sciences Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lg Life Sciences Ltd filed Critical Lg Life Sciences Ltd
Publication of AR012125A1 publication Critical patent/AR012125A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/16—Central respiratory analeptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/01—Sulfonic acids
    • C07C309/02—Sulfonic acids having sulfo groups bound to acyclic carbon atoms
    • C07C309/03—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C309/04—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing only one sulfo group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Urology & Nephrology (AREA)
  • Pulmonology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ARP980101268A 1997-03-21 1998-03-20 UNA SAL DE UN COMPUESTO DERIVADO DEL ÁCIDO NAFTIRIDINA CARBOXíLICO , SU USO PARA LA FABRICACIoN DE UN MEDICAMENTO , PROCEDIMIENTO PARA PREPARARLA Y UNA COMPOSICIoN FARMACÉUTICA QUE LO COMPRENDE AR012125A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR19970009840 1997-03-21

Publications (1)

Publication Number Publication Date
AR012125A1 true AR012125A1 (es) 2000-09-27

Family

ID=19500439

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP980101268A AR012125A1 (es) 1997-03-21 1998-03-20 UNA SAL DE UN COMPUESTO DERIVADO DEL ÁCIDO NAFTIRIDINA CARBOXíLICO , SU USO PARA LA FABRICACIoN DE UN MEDICAMENTO , PROCEDIMIENTO PARA PREPARARLA Y UNA COMPOSICIoN FARMACÉUTICA QUE LO COMPRENDE

Country Status (38)

Country Link
US (9) US7700617B2 (OSRAM)
EP (2) EP1179533B1 (OSRAM)
JP (3) JP3759962B2 (OSRAM)
KR (1) KR100266499B1 (OSRAM)
CN (1) CN1131229C (OSRAM)
AP (1) AP1331A (OSRAM)
AR (1) AR012125A1 (OSRAM)
AT (2) ATE257836T1 (OSRAM)
AU (1) AU726634B2 (OSRAM)
BG (1) BG63972B1 (OSRAM)
BR (1) BR9808290A (OSRAM)
CA (1) CA2283671C (OSRAM)
CZ (2) CZ288673B6 (OSRAM)
DE (2) DE69821147T2 (OSRAM)
DK (2) DK1179533T3 (OSRAM)
DZ (1) DZ2448A1 (OSRAM)
EA (1) EA001674B1 (OSRAM)
ES (2) ES2213669T3 (OSRAM)
HU (2) HU225412B1 (OSRAM)
ID (1) ID22681A (OSRAM)
IL (2) IL131812A (OSRAM)
IN (1) IN188178B (OSRAM)
IS (2) IS2093B (OSRAM)
MA (1) MA24500A1 (OSRAM)
MY (1) MY137653A (OSRAM)
NO (1) NO312515B1 (OSRAM)
NZ (1) NZ337748A (OSRAM)
OA (1) OA11161A (OSRAM)
PE (1) PE67999A1 (OSRAM)
PL (1) PL191815B1 (OSRAM)
PT (2) PT1179533E (OSRAM)
SA (1) SA98181055B1 (OSRAM)
SI (2) SI0981527T1 (OSRAM)
SK (1) SK284107B6 (OSRAM)
TR (1) TR199902313T2 (OSRAM)
UA (1) UA56218C2 (OSRAM)
WO (1) WO1998042705A1 (OSRAM)
ZA (1) ZA982335B (OSRAM)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9820405D0 (en) 1998-09-18 1998-11-11 Smithkline Beecham Plc Process
IL145238A0 (en) * 1999-03-19 2002-06-30 Knoll Gmbh Treatment of osteoarthritis
US6331550B1 (en) 1999-06-29 2001-12-18 Smithkline Beecham Corporation Methods of use of quinolone compounds against anaerobic pathogenic bacteria
US6262071B1 (en) 1999-06-29 2001-07-17 Smithkline Beecham Corporation Methods of use of antimicrobial compounds against pathogenic amycoplasma bacteria
CA2282066C (en) 1999-06-29 2010-09-07 Smithkline Beecham Corporation Methods of use of quinolone compounds against atypical upper respiratory pathogenic bacteria
US6803376B1 (en) 1999-06-29 2004-10-12 Smithkline Beecham Corporation Method of use of quinolone compounds against pneumococcal and haemophilus bacteria
GB9920917D0 (en) 1999-09-03 1999-11-10 Sb Pharmco Inc Novel process
GB9920919D0 (en) 1999-09-03 1999-11-10 Sb Pharmco Inc Novel compound
JP2001097864A (ja) * 1999-09-24 2001-04-10 Smithkline Beecham Corp 呼吸管および尿路病原性細菌に対するフルオロキノリン化合物の使用方法
WO2001021176A1 (en) * 1999-09-22 2001-03-29 Smithkline Beecham Corporation Methods of use of fluoroquinolone compounds against bacteria
GR1003520B (el) * 1999-09-22 2001-01-22 Smithkline Beecham Plc Μεθοδος χρησης ενωσεων φλουοροκινολονης εναντια σε νοσοκομειακα αρνητικα κατα gramμ παθογενων βακτηριδιων
JP2001097863A (ja) * 1999-09-24 2001-04-10 Smithkline Beecham Corp 嫌気性病原菌に対するフルオロキノロン化合物の使用法
JP2001097891A (ja) * 1999-09-24 2001-04-10 Smithkline Beecham Corp 呼吸器系病原菌に対するフルオロキノロン化合物の使用法
GR1003521B (el) * 1999-09-23 2001-01-22 Smithkline Beecham Plc Μεθοδοι χρησεως ενωσεων φλουοροκινολονης εναντια κατα gram θετικων παθογονων βακτηριδιων
KR20010091379A (ko) * 2000-03-15 2001-10-23 성재갑 7-(4-아미노메틸-3-옥심)피롤리딘 치환체를 갖는 퀴놀린카르복실산 유도체의 신규 제조방법
ES2314082T3 (es) 2001-08-02 2009-03-16 Lg Life Sciences Limited Procedimientos para la produccion de derivados amino protegidos de 4-aminometilenpirrolidin-3-ona, gemifloxacina y sus sales.
DE60222298T2 (de) * 2001-11-30 2008-01-03 Lg Life Sciences Ltd. Verfahren zur behandlung von bakteriellen infektionen mit gemifloxacin oder einem seiner salze und einem beta-lactam-antibiotikum
KR100517638B1 (ko) 2002-04-08 2005-09-28 주식회사 엘지생명과학 게미플록사신 산염의 새로운 제조방법
AR043880A1 (es) * 2003-04-22 2005-08-17 Solvay Pharm Gmbh Mesilato acido de 4-(4.trans-hidroxiciclohexil) amino-2-fenil-7h-pirrolo (2,3-d) pirimidina y sus formas polimorfas
EP1891037A1 (en) 2005-06-15 2008-02-27 Hetero Drugs Limited Gemifloxacin process and polymorphs
PL1993547T3 (pl) * 2006-03-07 2013-08-30 Wockhardt Ltd Proleki kwasu benzochinolizyno-2-karboksylowego
WO2010001408A2 (en) * 2008-06-06 2010-01-07 Matrix Laboratories Ltd. Novel polymorphic forms of gemifloxacin mesylate
WO2010146594A1 (en) * 2009-06-16 2010-12-23 Hetero Research Foundation Novel polymorphs of gemifloxacin mesylate
EP2491921A1 (en) 2011-02-25 2012-08-29 Deva Holding Anonim Sirketi Conservation of anhydrous form of gemifloxacin
KR102076118B1 (ko) * 2012-02-27 2020-02-11 브리스톨-마이어스 스큅 컴퍼니 N-(5S,6S,9R)-5-아미노-6-(2,3-디플루오로페닐)-6,7,8,9-테트라히드로-5H-시클로헵타[b]피리딘-9-일-4-(2-옥소-2,3-디히드로-1H-이미다조[4,5-b]피리딘-1-일)피페리딘-1-카르복실레이트, 헤미술페이트 염
CZ2016104A3 (cs) * 2016-02-24 2017-09-06 Zentiva, K.S. Krystalické modifikace solí methyl (3Z)-3-{[(4-{methyl[(4-methylpiperazin-1-yl)acetyl]amino}fenyl)amino](fenyl)methyliden}-2-oxo-2,3-dihydro-1H-indol-6-karboxylátu a způsoby jejich přípravy

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR223983A1 (es) 1978-08-25 1981-10-15 Dainippon Pharmaceutical Co Un procedimiento para-preparar derivados de acido 6-halogeno-4-oxo-7-(1-piperazinil)-1,8-naftiridin-3-carboxilico
ES8304117A1 (es) 1981-06-11 1983-02-16 Warner Lambert Co "un procedimiento para preparar sales de compuestos de naftiridina y quinoleina".
IN162769B (OSRAM) 1984-11-13 1988-07-09 Kyorin Seiyaku Kk
NZ222047A (en) 1986-10-08 1991-01-29 Bristol Myers Co Quinoline - or naphthyridine - carboxylic acid anti-bacterial agents
JPH01100165A (ja) 1987-10-13 1989-04-18 Shionogi & Co Ltd オキシムまたはヒドロキシアミン誘導体系抗菌剤
US4920120A (en) 1988-01-25 1990-04-24 Warner-Lambert Company Antibacterial agents
US4931446A (en) * 1988-03-23 1990-06-05 Abbott Laboratories Antimicrobial for in-vitro diagnostic kits
CA1336090C (en) * 1988-08-31 1995-06-27 Isao Hayakawa Spiro-substituted cyclic amines of quinolone derivatives
US5286723A (en) * 1988-08-31 1994-02-15 Daiichi Seiyaku Co., Ltd. Spiro compound
IE66202B1 (en) 1989-08-16 1995-12-13 Pfizer Azabicyclo quinolone carboxylic acids
US5276041A (en) 1991-11-08 1994-01-04 Kaken Pharmaceutical Co., Ltd. Oxime derivatives
WO1993025545A1 (en) 1992-06-09 1993-12-23 Korea Research Institute Of Chemical Technology Novel quinoline derivatives and processes for preparing the same
US5776944A (en) * 1994-06-16 1998-07-07 Lg Chemical Ltd. 7-(4-aminomethyl-3-methyloxyiminopyrroplidin-1-yl)-1-cyclopropyl-6-flu oro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid and the process for the preparation thereof
DE69509442T2 (de) * 1994-06-16 1999-09-02 Lg Chemical Ltd. Chinolincarbonsäurederivate mit 7-(4-Amino-methyl-3-oxim)-pyrrolidin-Substituenten und Verfahren zu ihrer Herstellung
WO1996012704A1 (fr) 1994-10-20 1996-05-02 Wakunaga Seiyaku Kabushiki Kaisha Nouveau derive de pyridone-carboxylate, ou sel de celui-ci, et antibacterien le contenant comme principe actif
CA2211681C (en) 1995-01-30 2003-05-13 Wakunaga Seiyaku Kabushiki Kaisha Novel pyridonecarboxylic acid derivatives or salts thereof and antibacterial agents comprising the same as active ingredient
CA2223404C (en) 1995-06-06 2001-01-16 Thomas A. Morris Novel crystal form of anhydrous 7-(¬1.alpha., 5.alpha., 6.alpha.|-6-amino-3-azabicyclo¬3.1.0|hex-3-yl)-6-fluoro-1-(2,4-difluorophenyl)-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acid, methanesulfonic acid salt
US20020032216A1 (en) * 1997-03-21 2002-03-14 Lg Chemical Ltd. Salt of naphthyridine carboxylic acid derivative
KR100286874B1 (ko) * 1998-03-04 2001-04-16 성재갑 보호된 4-아미노메틸-피롤리딘-3-온의 제조방법
GB9820405D0 (en) 1998-09-18 1998-11-11 Smithkline Beecham Plc Process

Also Published As

Publication number Publication date
PL335812A1 (en) 2000-05-22
US20100240694A1 (en) 2010-09-23
EP1179533A2 (en) 2002-02-13
SK284107B6 (sk) 2004-09-08
EA199900855A1 (ru) 2000-04-24
EA001674B1 (ru) 2001-06-25
ES2198697T3 (es) 2004-02-01
ATE257836T1 (de) 2004-01-15
NO312515B1 (no) 2002-05-21
NZ337748A (en) 2001-03-30
DZ2448A1 (fr) 2003-01-11
US20170253588A1 (en) 2017-09-07
AU6636698A (en) 1998-10-20
WO1998042705A1 (en) 1998-10-01
UA56218C2 (uk) 2003-05-15
DK0981527T3 (da) 2003-09-01
IS2095B (is) 2006-04-12
IS2093B (is) 2006-04-12
CN1251101A (zh) 2000-04-19
AU726634B2 (en) 2000-11-16
CA2283671C (en) 2003-09-16
JP2009051851A (ja) 2009-03-12
IL131812A (en) 2006-04-10
DE69814378D1 (de) 2003-06-12
AP1331A (en) 2004-11-26
CN1131229C (zh) 2003-12-17
TR199902313T2 (xx) 1999-12-21
JP2004002413A (ja) 2004-01-08
JP4781614B2 (ja) 2011-09-28
NO994595L (no) 1999-09-21
BG103750A (en) 2000-06-30
EP1179533A3 (en) 2002-03-20
EP0981527B1 (en) 2003-05-07
JP2000510484A (ja) 2000-08-15
PT1179533E (pt) 2004-05-31
HUP0000728A2 (hu) 2000-09-28
MY137653A (en) 2009-02-27
KR19980080504A (ko) 1998-11-25
DE69821147D1 (de) 2004-02-19
AP9901649A0 (en) 1999-09-30
BG63972B1 (bg) 2003-08-29
JP3759962B2 (ja) 2006-03-29
HUP0600401A3 (en) 2010-05-28
US20090182006A1 (en) 2009-07-16
PT981527E (pt) 2003-09-30
ES2213669T3 (es) 2004-09-01
OA11161A (en) 2003-04-25
ID22681A (id) 1999-12-09
IS5181A (is) 1999-09-14
SI1179533T1 (en) 2004-04-30
CZ328299A3 (cs) 2000-02-16
MA24500A1 (fr) 1998-10-01
US20160264569A1 (en) 2016-09-15
HU227536B1 (en) 2011-08-29
IN188178B (OSRAM) 2002-08-31
IL131812A0 (en) 2001-03-19
PL191815B1 (pl) 2006-07-31
SA98181055B1 (ar) 2006-10-11
DE69814378T2 (de) 2004-02-26
CZ288715B6 (cs) 2001-08-15
US7700617B2 (en) 2010-04-20
HK1026698A1 (en) 2000-12-22
KR100266499B1 (ko) 2000-12-01
US20140187576A1 (en) 2014-07-03
DK1179533T3 (da) 2004-05-03
CZ288673B6 (cs) 2001-08-15
IS7952A (is) 2005-07-21
ATE239724T1 (de) 2003-05-15
HU0600401D0 (en) 2006-07-28
SK123699A3 (en) 2000-08-14
EP0981527A1 (en) 2000-03-01
US20110312987A1 (en) 2011-12-22
NO994595D0 (no) 1999-09-21
CA2283671A1 (en) 1998-10-01
HU225412B1 (en) 2006-11-28
EP1179533B1 (en) 2004-01-14
HUP0000728A3 (en) 2002-12-28
DE69821147T2 (de) 2004-11-11
PE67999A1 (es) 1999-09-30
US20150291585A1 (en) 2015-10-15
ZA982335B (en) 1999-11-23
US20130065917A1 (en) 2013-03-14
BR9808290A (pt) 2000-05-16
SI0981527T1 (en) 2003-10-31
US20080039488A1 (en) 2008-02-14

Similar Documents

Publication Publication Date Title
AR012125A1 (es) UNA SAL DE UN COMPUESTO DERIVADO DEL ÁCIDO NAFTIRIDINA CARBOXíLICO , SU USO PARA LA FABRICACIoN DE UN MEDICAMENTO , PROCEDIMIENTO PARA PREPARARLA Y UNA COMPOSICIoN FARMACÉUTICA QUE LO COMPRENDE
GT199900069A (es) Preparaciones farmaceuticas estabilizadas de gabapentina y proceso para prepararla.
AR008586A1 (es) Compuesto derivado de aril alquilamina alfa, alfa-disustituido, composicion farmaceutica que lo contiene, metodo para la determinacion de la actividad calcilitica de un compuesto y uso de dichos compuestos para la fabricacion de un medicamento
AR008462A1 (es) COMPOSICIoN FARMACÉUTICA QUE COMPRENDE OLANZAPINA Y CLORHIDRATO DE FLUOXETINA Y USO DE DICHA COMPOSICIoN PARA LA FABRICACIoN DE UN MEDICAMENTO.
BR9909565A (pt) Derivados bicìclicos do ácido hidroxâmico
MX9204268A (es) Una composicion para la liberacion prolongada y controlada de substancias medicamentosas y un proceso para preparar la misma.
BR9801606B1 (pt) composto, processo para sua preparação, substáncia farmacêutica, uso do composto e processo para a produção de uma substáncia farmacêutica.
AR017205A1 (es) ANILIDAS MIMÉTICAS DE ÁCIDO RETINOICO, PROCESOS PARA PREPARAR DICHOS COMPUESTOS, COMPOSICIONES FARMACÉUTICAS QUE LOS COMPRENDEN, UN PROCESO PARA PREPARAR DICHAS COMPOSICIONES Y EL USO DE DICHOS COMPUESTOS EN LA ELABORACIoN DE MEDICAMENTOS.
MX9100990A (es) Compuesto monohidrato de furoato de mometasona,al procedimiento para su preparacion y a las composiciones farmaceuticas
AR011069A1 (es) Compuestos amidino, proceso para su preparacion, compuestos intermediarios, formulaciones farmaceuticas que los comprenden, y su uso en la fabricacion de un medicamento como inhibidor de la oxido nitrico sintasa inducible.
BR9807814B1 (pt) composto de pirazina, composiÇço farmacÊutica, uso de um composto, e, processo para a preparaÇço de um composto.
BR1100850A (pt) Composto, processo para a preparação de um composto, e, composição farmacêutica
AR004700A1 (es) 1alfa, 26 dihidroxi-d-homo-vitamina d3, una composicion farmaceutica que la comprende, un procedimiento para su preparacion y el uso de los mismos en laelaboracion de un medicamento
PT1339675E (pt) Compostos bisarilo orto, meta-substituidos, processo para a sua preparacao, sua utilizacao como medicamentos e composicoes farmaceuticas que os contem
MX22877A (es) Procedimiento para la preparacion de pirimidas, producto obtenido y composicion farmaceutica que lo incluye
AR021347A1 (es) Una composicion farmaceutica que contiene acido(s) bisfosfoncio o sal(es) del mismo y un proceso de preparacion de la misma
PT1098874E (pt) Benzociclo-heptenos processo para a sua sintese preparacoes farmaceuticas contendo estes compostos assim como sua utilizacao para a fabricacao de medicamentos
PT1042323E (pt) Novos analogos tetraciclicos de camptotecinas processos para a sua preparacao sua utilizacao como medicamentos e composicoes farmaceuticas que os contem
BR9808422B1 (pt) composto, composiÇço farmacÊutica, uso de um composto, e, processo para a preparaÇço de um composto.
ES2017899A4 (es) Derivados xantino que tienen actividad broncodilatadora, un proceso para la preparacion de ello y compuestos farmaceuticos que los contienen
AR010399A1 (es) DERIVADOS DE AMIDAS DE LOS ÁCIDOS ISOXAZoLICO Y CROToNICO , PROCEDIMIENTO PARA SU PREPARACIoN MEDICAMENTO QUE LOS CONTIENE Y SU UTILIZACIoN COMO MEDICAMENTOS Y COMO AGENTES DE DIAGNoSTICO
PT1165081E (pt) Processo para a preparacao de preparacoes farmaceuticas cintendo tolperisona, para administracao oral
ITMI941262A0 (it) Composizione farmaceutica solida contenente acido (s)-2-(4- isobutilfenil) propionico come principio attivo
BR0107899A (pt) Processo para produzir uma preparação de ingrediente ativo compreendendo ibuprofeno, preparação de ingrediente ativo, uso da mesma, preparação farmacêutica, uso da mesma, processo para produzir formas de dosagem sólidas, e, forma de dosagem sólida
AR026072A1 (es) Composicion farmaceutica que contiene ciclesonida para aplicacion a la mucosa

Legal Events

Date Code Title Description
FG Grant, registration